Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 3198: Hyperactive c-Met and ErbB signaling detected in a sub-group of ovarian patient tumors: Patient sub-group may benefit from c-Met and pan-HER combination therapy

Cancer Res (2020) 80 (16_Supplement): 3198.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal